Improving Negative Symptoms and Community Engagement in Veterans With Schizophrenia

The goal of this study is to evaluate an innovative psychosocial intervention package that
will incorporate evidence-based treatment strategies to target the affective-motivational
deficits, negative expectancies, and behavioral skills deficits that are central to the
maintenance of negative symptoms. The intervention - called Engaging in Community Roles &
Experiences (ENCoRE) - will include strategies aimed at teaching Veterans with schizophrenia
and negative symptoms ways to (1) overcome deficits in anticipatory pleasure, (2) increase
intrinsic motivation for goal-directed activities, (3) reduce expectancies for failure, and
(4) perform skillfully in new social situations, all of which can impact implementation of
new skills and behaviors. Rather than develop a new set of intervention strategies, we will
include within EnCoRE evidence-based strategies for these treatment domains. In addition,
the investigators will collect qualitative information both from Veterans concerning their
perceptions of the strengths, weaknesses, and barriers to participation in EnCoRE, as well
as from a sample of mental health providers who work with Veterans with schizophrenia and
negative symptoms, in order to inform a larger scale implementation trial should EnCoRE
prove effective here.

Following a short pilot to train interventionists and refine the manual, the investigators
will conduct a randomized controlled trial to test the efficacy of EnCoRE in improving
ratings of negative symptoms, functional outcomes, and engagement in community activities in
a sample of Veterans with schizophrenia and negative symptoms (n=108). Participants will be
randomized either to EnCoRE or a health-related control group. Specifically, the
investigators will address the following Specific Aims:

Specific Aim 1: Train therapists and refine the EnCoRE manual in a preliminary trial with 10
Veterans with schizophrenia and negative symptoms.

Specific Aim 2: Conduct a randomized controlled trial (n=108, medium effect, alpha=.05) to
test the efficacy of EnCoRE in producing positive changes at post-treatment and 3-month
follow-up on the primary outcomes of negative symptoms and social and community functioning.

Specific Aim 3: Examine qualitative interviews completed by (1) Veterans who participated in
EnCoRE and (2) Mental Health Providers to determine aspects of EnCoRE that were perceived as
more or less helpful, interesting, and valuable in order to make adjustments prior to
conducting a larger, multi-site implementation trial.

Inclusion Criteria:

1. Diagnostic and Statistical Manual of Disorders, 5th edition (DSM 5) diagnosis of
schizophrenia or schizoaffective disorder

2. A minimum average rating of a "moderate deficit" (2 or greater on a 0 4 scale) on any
symptom domain within the affect motivation factor (i.e., symptoms of asociality,
avolition, and anhedonia) of the Clinical Assessment Interview for Negative Symptoms
(CAINS)

3. Age between 18 and 75 years

4. Seen by a mental health professional at the recruitment site at least once every 3
months for the last 6 months (to demonstrate that participants receive ongoing and
regular mental health care);

5. Competent to sign Informed Consent

Exclusion Criteria:

1. Documented history of serious neurological disorder or head trauma with loss of
consciousness

2. Cognitive impairment (defined as a total IQ score less than 70 as measured by the
Wechsler Test of Adult Reading or as indicated by chart review

3. Inability to effectively participate in the baseline assessments due to psychiatric
symptoms on two successive appointments

4. Current problematic substance use as indexed by scores on the Michigan Alcoholism
Screening Test and the Drug Abuse Screening Test

5. Currently meet criteria for a major depressive episode